Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138406483> ?p ?o ?g. }
- W3138406483 endingPage "3135" @default.
- W3138406483 startingPage "3135" @default.
- W3138406483 abstract "The study of metabolic deregulation in myeloid malignancies has led to the investigation of metabolic-targeted therapies considering that cells undergoing leukemic transformation have excessive energy demands for growth and proliferation. However, the most difficult challenge in agents targeting metabolism is to determine a window of therapeutic opportunities between normal and neoplastic cells, considering that all or most of the metabolic pathways important for cancer ontogeny may also regulate physiological cell functions. Targeted therapies have used the properties of leukemic cells to produce altered metabolic products when mutated. This is the case of IDH1/2 mutations generating the abnormal conversion of α-ketoglutarate (KG) to 2-hydroxyglutarate, an oncometabolite inhibiting KG-dependent enzymes, such as the TET family of genes (pivotal in characterizing leukemia cells either by mutations, e.g., TET2, or by altered expression, e.g., TET1/2/3). Additional observations derive from the high sensitivity of leukemic cells to oxidative phosphorylation and its amelioration using BCL-2 inhibitors (Venetoclax) or by disrupting the mitochondrial respiration. More recently, nicotinamide metabolism has been described to mediate resistance to Venetoclax in patients with acute myeloid leukemia. Herein, we will provide an overview of the latest research on the link between metabolic pathways interactome and leukemogenesis with a comprehensive analysis of the metabolic consequences of driver genetic lesions and exemplificative druggable pathways." @default.
- W3138406483 created "2021-03-29" @default.
- W3138406483 creator A5016847107 @default.
- W3138406483 creator A5059441718 @default.
- W3138406483 creator A5066332957 @default.
- W3138406483 date "2021-03-19" @default.
- W3138406483 modified "2023-10-09" @default.
- W3138406483 title "The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies" @default.
- W3138406483 cites W1484931598 @default.
- W3138406483 cites W1773238988 @default.
- W3138406483 cites W1847894796 @default.
- W3138406483 cites W1851726948 @default.
- W3138406483 cites W1964809738 @default.
- W3138406483 cites W1976573435 @default.
- W3138406483 cites W1981463058 @default.
- W3138406483 cites W1987761030 @default.
- W3138406483 cites W1992492146 @default.
- W3138406483 cites W1992913613 @default.
- W3138406483 cites W1995091371 @default.
- W3138406483 cites W1995675594 @default.
- W3138406483 cites W1999653222 @default.
- W3138406483 cites W2003168484 @default.
- W3138406483 cites W2005458309 @default.
- W3138406483 cites W2009397177 @default.
- W3138406483 cites W2010885293 @default.
- W3138406483 cites W2017190603 @default.
- W3138406483 cites W2026134786 @default.
- W3138406483 cites W2028078153 @default.
- W3138406483 cites W2031050244 @default.
- W3138406483 cites W2038449573 @default.
- W3138406483 cites W2040795628 @default.
- W3138406483 cites W2046938310 @default.
- W3138406483 cites W2047122678 @default.
- W3138406483 cites W2064318320 @default.
- W3138406483 cites W2067589134 @default.
- W3138406483 cites W2068050716 @default.
- W3138406483 cites W2068128334 @default.
- W3138406483 cites W2072713007 @default.
- W3138406483 cites W2073889874 @default.
- W3138406483 cites W2074516296 @default.
- W3138406483 cites W2081895311 @default.
- W3138406483 cites W2082312262 @default.
- W3138406483 cites W2085293170 @default.
- W3138406483 cites W2086974150 @default.
- W3138406483 cites W2087390915 @default.
- W3138406483 cites W2095066915 @default.
- W3138406483 cites W2102461774 @default.
- W3138406483 cites W2104852749 @default.
- W3138406483 cites W2111768081 @default.
- W3138406483 cites W2116205277 @default.
- W3138406483 cites W2118519201 @default.
- W3138406483 cites W2122559865 @default.
- W3138406483 cites W2127738065 @default.
- W3138406483 cites W2143812686 @default.
- W3138406483 cites W2144892629 @default.
- W3138406483 cites W2150680216 @default.
- W3138406483 cites W2164305025 @default.
- W3138406483 cites W2167275598 @default.
- W3138406483 cites W2284984697 @default.
- W3138406483 cites W2300145034 @default.
- W3138406483 cites W2419140434 @default.
- W3138406483 cites W2485884487 @default.
- W3138406483 cites W2549294004 @default.
- W3138406483 cites W2555224212 @default.
- W3138406483 cites W2558961618 @default.
- W3138406483 cites W2575423147 @default.
- W3138406483 cites W2585860512 @default.
- W3138406483 cites W2588498659 @default.
- W3138406483 cites W2608857438 @default.
- W3138406483 cites W2614352808 @default.
- W3138406483 cites W2623089849 @default.
- W3138406483 cites W2746373891 @default.
- W3138406483 cites W2746871805 @default.
- W3138406483 cites W2750794123 @default.
- W3138406483 cites W2756786254 @default.
- W3138406483 cites W2771968670 @default.
- W3138406483 cites W2774170088 @default.
- W3138406483 cites W2791744951 @default.
- W3138406483 cites W2803830650 @default.
- W3138406483 cites W2806682325 @default.
- W3138406483 cites W2808587354 @default.
- W3138406483 cites W2810336146 @default.
- W3138406483 cites W2883635070 @default.
- W3138406483 cites W2884558319 @default.
- W3138406483 cites W2884819478 @default.
- W3138406483 cites W2887948931 @default.
- W3138406483 cites W2889993921 @default.
- W3138406483 cites W2890413816 @default.
- W3138406483 cites W2891055002 @default.
- W3138406483 cites W2894043033 @default.
- W3138406483 cites W2897143766 @default.
- W3138406483 cites W2898284215 @default.
- W3138406483 cites W2899472109 @default.
- W3138406483 cites W2901585624 @default.
- W3138406483 cites W2903557808 @default.
- W3138406483 cites W2912914678 @default.
- W3138406483 cites W2920849273 @default.
- W3138406483 cites W2926077039 @default.